Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Vaccines market. The report considers 2021-2024 historic period, 2025 as base year, and 2026-2035 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition.
Vaccines market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid databases such as FACIVA, Hoovers, and other benchmarking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Vaccines market is estimated to expand at a considerable growth rate during the forecast period owing to the increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products, leading to increased utilization of the Vaccines products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Vaccines products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Vaccines market.
To learn more about this report
Increasing research and development spending on Vaccines development has been the leading industry trend of Vaccines market
The leading players in the market are focused on developing products which are cost-effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be witnessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2025 | USD XX.XX Million |
| CAGR (2026 - 2035) | XX.XX % |
| The Revenue forecast in 2035 | USD XX.XX Million |
| Base year for estimation | 2025 |
| Historical data | 2021-2024 |
| Forecast period | 2026-2035 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Product Outlook, Distribution Channel Outlook, Regional Outlook |
| By Product Outlook | Inactivated Vaccines, Live-Attenuated Vaccines, Recombinant Vaccines, Viral Vector, m-RNA, Others |
| By Distribution Channel Outlook | Public Health Programs, Hospital Pharmacies, Retail Pharmacies, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Pfizer Inc, GlaxoSmithKline plc (GSK), Sanofi S.A., Merck & Co., Inc. (MSD), Johnson and Johnson, AstraZeneca Plc, Serum Institute of India Pvt. Ltd, Moderna, Inc, Bharat Biotech International Ltd, CSL Ltd |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
Table of Contents
Chapter 1 Vaccines Market Overview
1.1 Vaccines Definition
1.2 Global Vaccines Market Size Status and Outlook (2021-2027)
1.3 Global Vaccines Market Size Comparison by Region (2021-2027)
1.4 Global Vaccines Market Size Comparison by Type (2021-2027)
1.5 Global Vaccines Market Size Comparison by Application (2021-2027)
1.6 Global Vaccines Market Size Comparison by Sales Channel (2021-2027)
1.7 Vaccines Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Vaccines Market Segment Analysis by Player
2.1 Global Vaccines Sales and Market Share by Player (2017-2020)
2.2 Global Vaccines Revenue and Market Share by Player (2017-2020)
2.3 Global Vaccines Average Price by Player (2017-2020)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Vaccines Market Segment Analysis by Type
3.1 Global Vaccines Market by Type
3.1.1 Recombinant Vaccines
3.1.2 Viral Vaccines
3.1.3 Polysaccharide Vaccines
3.1.4 Others
3.2 Global Vaccines Sales and Market Share by Type (2017-2020)
3.3 Global Vaccines Revenue and Market Share by Type (2017-2020)
3.4 Global Vaccines Average Price by Type (2017-2020)
3.5 Leading Players of Vaccines by Type in 2020
3.6 Conclusion of Segment by Type
Chapter 4 Vaccines Market Segment Analysis by Application
4.1 Global Vaccines Market by Application
4.1.1 Cholera
4.1.2 Hepatitis B
4.1.3 Diphtheria
4.1.4 Tetanus
4.1.5 Measles vaccine
4.2 Global Vaccines Sales and Market Share by Application (2017-2020)
4.3 Leading Consumers of Vaccines by Application in 2020
4.4 Conclusion of Segment by Application
Chapter 5 Vaccines Market Segment Analysis by Sales Channel
5.1 Global Vaccines Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Vaccines Sales and Market Share by Sales Channel (2017-2020)
5.3 Leading Distributors/Dealers of Vaccines by Sales Channel in 2020
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Vaccines Market Segment Analysis by Region
6.1 Global Vaccines Market Size and CAGR by Region (2021-2027)
6.2 Global Vaccines Sales and Market Share by Region (2017-2020)
6.3 Global Vaccines Revenue and Market Share by Region (2017-2020)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Vaccines Market Share by Type
6.4.3 North America Vaccines Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Vaccines Market Share by Type
6.5.3 Europe Vaccines Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Vaccines Market Share by Type
6.6.3 Asia-Pacific Vaccines Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Vaccines Market Share by Type
6.7.3 South America Vaccines Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Vaccines Market Share by Type
6.8.3 Middle East & Africa Vaccines Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Vaccines Players
7.1 GSK
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Sanofi
7.3 Merck
7.4 Pfizer
7.5 Novartis(GSK)
7.6 CSL
7.7 MedImmune LLC
7.8 J&J(Crucell)
7.9 China National Biotec
7.10 Tiantan
7.11 Hualan
7.12 Kangtai
7.13 Hissen
7.14 Jintan
Chapter 8 Upstream and Downstream Analysis of Vaccines
8.1 Industrial Chain of Vaccines
8.2 Upstream of Vaccines
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Vaccines
8.3.1 Leading Distributors/Dealers of Vaccines
8.3.2 Leading Consumers of Vaccines
Chapter 9 Development Trend of Vaccines (2021-2027)
9.1 Global Vaccines Market Size (Sales and Revenue) Forecast (2021-2027)
9.2 Global Vaccines Market Size and CAGR Forecast by Region (2021-2027)
9.3 Global Vaccines Market Size and CAGR Forecast by Type (2021-2027)
9.4 Global Vaccines Market Size and CAGR Forecast by Application (2021-2027)
9.5 Global Vaccines Market Size Forecast by Sales Channel (2021-2027)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
